Everything You Need to Know About Glycolysis regulation for Step 1

Glycolysis regulation is one of those Step 1 topics that feels “basic” until a question quietly tests it through sepsis, alcoholism, high-altitude physiology, a pyruvate kinase deficiency smear, or a poisoned ETC. If you can explain why glycolysis speeds up or slows down in a given tissue—and what happens when it can’t—you’ll turn a lot of biochem vignettes into free points.

---

Big-picture definition (what you’re actually regulating)

Glycolysis is a cytosolic pathway that converts glucose → pyruvate, generating:

• Net ATP: 2 ATP per glucose (aerobic or anaerobic)
• Net NADH: 2 NADH per glucose (must be reoxidized to keep glycolysis going)

Key branching:

• Aerobic: pyruvate → acetyl-CoA (mitochondria) → TCA/ETC
• Anaerobic / no mitochondria (RBCs): pyruvate → lactate (regenerates NAD⁺)

What “glycolysis regulation” means on exams: control of flux through the pathway (rate), primarily at irreversible steps.

---

The 3 irreversible steps (memorize these cold)

First Aid cross-reference: Biochemistry → Glycolysis (enzymes, irreversible steps, regulation by insulin/glucagon); Hereditary hemolytic anemias (pyruvate kinase deficiency).

---

The master switch: PFK-1 and fructose-2,6-bisphosphate (F2,6BP)

If you remember one regulatory molecule for glycolysis, make it F2,6BP.

What F2,6BP does

• Activates PFK-1 → increases glycolysis
• Inhibits fructose-1,6-bisphosphatase (FBPase-1) → decreases gluconeogenesis

So F2,6BP pushes the cell toward burning glucose, not making it.

Who controls F2,6BP?

A bifunctional enzyme: PFK-2 / FBPase-2

• PFK-2 makes F2,6BP (from F6P)
• FBPase-2 breaks down F2,6BP

Insulin vs glucagon (liver is the classic test site)

High-yield concept: The liver “chooses” glycolysis vs gluconeogenesis based heavily on F2,6BP.

First Aid cross-reference: Biochemistry → Glycolysis regulation (PFK-2/FBPase-2, F2,6BP); Endocrine → Insulin vs glucagon signaling.

---

Hexokinase vs glucokinase (don’t mix them up)

Hexokinase (most tissues)

• High affinity (low $K_m$) → works well even at low glucose
• Low capacity (low $V_{max}$)
• Inhibited by G6P (product inhibition)
• Role: ensure tissues can trap glucose as G6P for energy

Glucokinase (liver + pancreatic β cells)

• Low affinity (high $K_m$) → only really active when glucose is high (fed state)
• High capacity (high $V_{max}$)
• Induced by insulin
• Not inhibited by G6P
• In liver: promotes glucose uptake for glycogen synthesis and glycolysis
• In β cells: part of glucose sensing → insulin release

Clinical association (HY): MODY2

• Glucokinase mutation → higher set point for insulin release
• Mild fasting hyperglycemia, often no severe complications
• Often managed with lifestyle

First Aid cross-reference: Biochemistry → Hexokinase vs Glucokinase; Endocrine → MODY.

---

Pyruvate kinase regulation (and why RBCs care)

Pyruvate kinase is the last irreversible step; regulation differs by tissue.

Key regulators

• Activated by F1,6BP (feed-forward activation)
• Inhibited by ATP and alanine (signals energy and building blocks are plentiful)
• In liver: glucagon → PKA → phosphorylation → inhibits pyruvate kinase
  (spares substrates for gluconeogenesis during fasting)

Clinical: Pyruvate kinase deficiency (super high-yield)

Pathophysiology

• ↓ pyruvate kinase → ↓ ATP production in RBCs
• RBCs rely entirely on glycolysis for ATP → membrane pump failure → hemolysis
• Shunt toward 2,3-BPG increases → right shift (↓ Hb-O₂ affinity)

Clinical presentation

• Chronic hemolytic anemia
• Jaundice, splenomegaly
• Neonatal hyperbilirubinemia possible

Diagnosis

• Hemolytic anemia labs: ↑ retic, ↑ LDH, ↓ haptoglobin, ↑ indirect bilirubin
• Peripheral smear: echinocytes (burr cells)
• Enzyme assay/genetic testing if needed

Treatment

• Supportive (folate), transfusions if severe
• Splenectomy can help in select cases

First Aid cross-reference: Hematology → Pyruvate kinase deficiency (burr cells, ↑2,3-BPG); Biochemistry → Glycolysis enzymes.

---

Redox control: NAD⁺ availability is a hidden rate-limiter

Glycolysis needs NAD⁺ (at glyceraldehyde-3-phosphate dehydrogenase). If NADH can’t be oxidized back to NAD⁺, glycolysis stalls.

How cells regenerate NAD⁺

• Aerobic: NADH donates electrons to the ETC (mitochondria)
• Anaerobic: lactate dehydrogenase converts pyruvate → lactate, regenerating NAD⁺

HY implication: Any state with impaired oxidative phosphorylation (hypoxia, shock, mitochondrial poisons) pushes pyruvate → lactate → lactic acidosis.

---

Pathophysiology: what happens when regulation goes wrong?

1) Hypoxia/ischemia/sepsis → ramp up anaerobic glycolysis → lactic acidosis

• ↓ O₂ → ↓ ETC → ↑ NADH / ↓ NAD⁺ regeneration
• Pyruvate shunted to lactate to regenerate NAD⁺
• Lactate rises, anion gap metabolic acidosis

Clinical presentation

• Tachypnea (compensation), altered mental status, hypotension (sepsis)
• Elevated lactate often tracks severity in shock

Diagnosis

• ABG/CMP: anion gap metabolic acidosis
• Serum lactate elevated
• Underlying cause evaluation (sepsis workup, ischemia, etc.)

Treatment (principles)

• Treat underlying cause (fluids/pressors/antibiotics for septic shock; restore perfusion/oxygenation)
• Remove offending agents if toxin-related

First Aid cross-reference: Acid-base disorders; Shock; Biochemistry → anaerobic glycolysis & lactate.

---

2) Pyruvate dehydrogenase (PDH) problems indirectly increase glycolysis → lactate

PDH connects glycolysis to TCA. If PDH is inhibited, pyruvate accumulates and is converted to lactate.

Causes

• PDH deficiency (genetic)
• Thiamine (B1) deficiency (PDH cofactor)
• Arsenic poisoning (inhibits lipoic acid)

Presentation

• Neurologic deficits, lactic acidosis (esp in infants/children for PDH deficiency)
• Wernicke-Korsakoff / beriberi signs for thiamine deficiency

Treatment

• Thiamine supplementation if deficient
• For PDH deficiency: ketogenic diet sometimes used (reduce glucose reliance)

First Aid cross-reference: PDH complex & cofactors (TPP/B1, lipoic acid, CoA/B5, FAD/B2, NAD/B3).

---

3) Alcohol metabolism shifts redox state → blocks gluconeogenesis, favors lactate

Ethanol metabolism generates lots of NADH (via alcohol dehydrogenase and aldehyde dehydrogenase).

• High NADH drives:
  • pyruvate → lactate (→ lactic acidosis)
  • oxaloacetate → malate (→ ↓ gluconeogenesis)
• Result: fasting hypoglycemia in alcohol use, plus metabolic derangements

Presentation

• Hypoglycemic symptoms (diaphoresis, confusion)
• Possible lactic acidosis

Treatment

• Thiamine before glucose in suspected malnutrition/alcohol use disorder
• Dextrose as needed after thiamine

First Aid cross-reference: Alcohol metabolism; Hypoglycemia; Vitamin deficiencies.

---

Clinical “presentation” of glycolysis regulation tested on Step 1/2 (what vignettes look like)

You’re rarely asked “what regulates glycolysis?” directly. Instead, you’ll see:

• A fasting patient: glucagon high → liver decreases glycolysis, increases gluconeogenesis
  Expect: ↓ F2,6BP, PFK-1 less active, pyruvate kinase inhibited (liver)
• A fed patient after carb-heavy meal: insulin high → liver increases glycolysis and glycogen synthesis
  Expect: ↑ F2,6BP, PFK-1 active
• Exercising skeletal muscle: AMP high, ATP low → PFK-1 activated (local control dominates)
• RBCs: always reliant on glycolysis; defects cause hemolysis; increased 2,3-BPG shifts curve right
• Sepsis/shock/hypoxia: lactate high due to anaerobic metabolism

---

Diagnosis: what labs point you toward glycolysis-related pathology?

---

Treatment: regulation-focused “moves” worth knowing

• Restore oxygen/perfusion (hypoxia/ischemia/shock): reduces lactate production by allowing oxidative metabolism
• Treat sepsis early (fluids, antibiotics, source control): lactate improves as perfusion improves
• Thiamine repletion when at risk (alcohol use disorder, malnutrition): supports PDH and other dehydrogenases
• Enzyme deficiency care (e.g., pyruvate kinase): supportive hematologic management, sometimes splenectomy

---

High-yield Step facts & associations (rapid review)

Absolute must-knows

• PFK-1 is the rate-limiting step of glycolysis.
• F2,6BP activates PFK-1 and inhibits gluconeogenesis (via FBPase-1 inhibition).
• Insulin increases glycolysis in liver by increasing F2,6BP (PFK-2 active).
• Glucagon decreases glycolysis in liver by decreasing F2,6BP (FBPase-2 active).
• RBCs depend entirely on glycolysis for ATP.

Classic associations

• Pyruvate kinase deficiency → chronic hemolysis + burr cells + ↑ 2,3-BPG (right shift).
• Hypoxia/mitochondrial dysfunction → ↑ lactate.
• Alcohol use → ↑ NADH → pyruvate → lactate + impaired gluconeogenesis → hypoglycemia.
• Glucokinase (β cells/liver) has high $K_m$ and high $V_{max}$; mutation can cause MODY2.

---

“If they give you X, think Y” mini-table

---

Quick self-check questions (the kind Step 1 loves)

1. Why does glucagon decrease glycolysis in the liver but exercising muscle still increases glycolysis?
   Because liver is hormonally regulated via PKA and F2,6BP, while muscle glycolysis is dominated by local energy signals (↑ AMP activates PFK-1).

2. What single molecule best explains the insulin/glucagon switch between glycolysis and gluconeogenesis?
   F2,6BP.

3. Why does lactate rise when oxygen is low?
   Lactate production regenerates NAD⁺ so glycolysis can continue.